| scholarly article | Q13442814 |
| P50 | author | Hauke Schneider | Q60651369 |
| Peter Kraft | Q88740867 | ||
| Matthias Endres | Q15441092 | ||
| Jens Volkmann | Q41011750 | ||
| Gereon Rudolf Fink | Q1511131 | ||
| P2093 | author name string | Stefan Schwab | |
| Joseph Classen | |||
| Arnd Dörfler | |||
| Peter D Schellinger | |||
| Christian Dohmen | |||
| Martin Köhrmann | |||
| Heinz Reichmann | |||
| Tobias Neumann-Haefelin | |||
| Jan Sobesky | |||
| Joachim Röther | |||
| Albrecht Günther | |||
| Markus Horn | |||
| Hansjörg Bäzner | |||
| Johannes Wöhrle | |||
| Michael Schwarz | |||
| Eric Jüttler | |||
| Armin Grau | |||
| Hagen B Huttner | |||
| Frederick Palm | |||
| Frank Erbguth | |||
| Joji B Kuramatsu | |||
| Stefan T Gerner | |||
| Stephan P Kloska | |||
| Gerhard F Hamann | |||
| Christoph Terborg | |||
| Gernot Reimann | |||
| Julia Flechsenhar | |||
| Carsten Hobohm | |||
| Henning Stetefeld | |||
| Wolfgang Müllges | |||
| Georg Hagemann | |||
| Hermann Neugebauer | |||
| Jörg Glahn | |||
| Martin Nueckel | |||
| Peter Michels | |||
| Otto Witte | |||
| Moritz Keller | |||
| Eik Schimmel | |||
| Frank Trostdorf | |||
| Aletta Roth | |||
| Andras E Racs | |||
| Angelika Milewski | |||
| Beatrice Barber | |||
| Joachim Hüwel | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anticoagulation | Q63279445 |
| anticoagulant | Q215118 | ||
| P1104 | number of pages | 13 | |
| P304 | page(s) | 824-836 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage | |
| P478 | volume | 313 |
| Q38647787 | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| Q53343255 | 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study. |
| Q47548974 | A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). |
| Q50653531 | Acute focal neurological deficits in the emergency room |
| Q59333336 | American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy |
| Q91765943 | An Intracerebral Hemorrhage Care Bundle Is Associated with Lower Case Fatality |
| Q92508817 | Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage |
| Q55047549 | Anticoagulation Resumption After Intracerebral Hemorrhage. |
| Q30975560 | Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds |
| Q88000130 | Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review |
| Q53281342 | Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review. |
| Q89641591 | Antithrombotic therapy in patients with non-traumatic intracerebral haemorrhage and atrial fibrillation: A retrospective study |
| Q24185972 | Antithrombotic treatment after intracerebral haemorrhage |
| Q36379755 | Antithrombotic treatment after stroke due to intracerebral haemorrhage. |
| Q38448388 | Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis. |
| Q42373137 | Antithrombotics in trauma: management strategies in the older patients |
| Q89871795 | Are Direct Anticoagulants Safer in Traumatic Brain Injury Compared to Warfarin? |
| Q90588245 | Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage |
| Q47185519 | Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist-Associated Intracerebral Hemorrhage. |
| Q57626264 | Can biomarkers balance stroke and bleeding risk? |
| Q57789140 | Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage |
| Q52848552 | Catheter-based closure of the left atrial appendage : Stroke prevention in atrial fibrillation |
| Q31108748 | Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment |
| Q98194136 | Clinical Impact of Hematoma Expansion in Left Ventricular Assist Device Patients |
| Q57820704 | Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage |
| Q101133189 | Clinical and radiological characteristics and outcome of wake-up intracerebral hemorrhage |
| Q38801187 | Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants |
| Q50497667 | Crew resource management and simulator training in acute stroke therapy |
| Q50062218 | Current treatment concepts in intracerebral hemorrhage |
| Q36281975 | Cutting delays in reversing anticoagulation after intracerebral haemorrhage: three key changes at a UK comprehensive stroke centre |
| Q31136660 | Diagnosis and Management of Acute Intracerebral Hemorrhage |
| Q38961751 | Direct Oral Anticoagulants in Emergency Trauma Admissions. |
| Q50123510 | Direct oral anticoagulant reversal: how, when and issues faced |
| Q88684953 | Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry - The TAC 2 Study |
| Q47967378 | Epileptic Seizures in Patients Following Surgical Treatment of Acute Subdural Hematoma-Incidence, Risk Factors, Patient Outcome, and Development of New Scoring System for Prophylactic Antiepileptic Treatment (GATE-24 score). |
| Q52654889 | Evaluation of a protocol for early detection of delayed brain hemorrhage in head injured patients on warfarin |
| Q37580876 | Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis |
| Q57175076 | Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial |
| Q39683385 | Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial |
| Q39042527 | Functional Long-Term Outcome after Left- versus Right-Sided Intracerebral Hemorrhage |
| Q58703004 | Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study |
| Q38682353 | Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. |
| Q88365944 | Haematoma expansion and vitamin K antagonist reversal |
| Q90059386 | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
| Q39209982 | Hemostasis in Intracranial Hemorrhage |
| Q53838560 | Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil. |
| Q38634835 | How to effectively manage the event of bleeding complications when using anticoagulants |
| Q52560337 | Hyperacute management of intracerebral haemorrhage |
| Q26797275 | Imaging of prehospital stroke therapeutics |
| Q57168432 | Impact of Recent Studies for the Treatment of Intracerebral Hemorrhage |
| Q58784494 | Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage |
| Q97425278 | Influence of time to admission to a comprehensive stroke centre on the outcome of patients with intracerebral haemorrhage |
| Q47883450 | Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference |
| Q57823179 | Integration of Computed Tomographic Angiography Spot Sign and Noncontrast Computed Tomographic Hypodensities to Predict Hematoma Expansion |
| Q53834433 | Intensive blood-pressure lowering in patients with acute cerebral hemorrhage |
| Q52147059 | Intracerebral haemorrhage, atrial fibrillation, and anticoagulation |
| Q57482499 | Intracerebral haemorrhage: current approaches to acute management |
| Q38671522 | Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation |
| Q89985305 | Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage |
| Q48626887 | Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. |
| Q49707565 | Management of Complications in Anticoagulated Patients with Atrial Fibrillation |
| Q58090317 | Management of Patients with Acute Subdural Hemorrhage During Treatment with Direct Oral Anticoagulants |
| Q41531083 | Management of Spontaneous Intracerebral Hemorrhage |
| Q40478828 | Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. |
| Q52807848 | Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves |
| Q39010418 | Medical management of intracerebral haemorrhage. |
| Q90198322 | Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use |
| Q89586524 | Neurosurgical Management and Outcomes of Cerebrovascular Disease in Pediatric Patients with Heart Disease |
| Q87017737 | New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series |
| Q57494697 | Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes |
| Q26750767 | Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues |
| Q47291019 | Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage |
| Q47839864 | Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. |
| Q54127394 | Oral anticoagulant-associated intracerebral haemorrhage |
| Q88691325 | Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage |
| Q38826151 | Overview of direct oral anticoagulant therapy reversal |
| Q26781769 | Perioperative atrial fibrillation: a systematic review of evolving therapeutic options in pharmacologic and procedural management |
| Q87357276 | Practical Guide to Direct New Oral Anticoagulant Use for Secondary Stroke Prevention in Atrial Fibrillation |
| Q38646426 | Presence of Concomitant Systemic Cancer is Not Associated with Worse Functional Long-Term Outcome in Patients with Intracerebral Hemorrhage. |
| Q36331578 | Proposal for the Rapid Reversal of Coagulopathy in Patients with Nonoperative Head Injuries on Anticoagulants and/or Antiplatelet Agents: A Case Study and Literature Review |
| Q57808968 | Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-anal |
| Q54233540 | Rapid reversal of haematoma expansion associated with vitamin K antagonists |
| Q38939453 | Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed |
| Q28067358 | Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed |
| Q64079483 | Recent advances in spontaneous intracerebral hemorrhage |
| Q36188813 | Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects |
| Q34555332 | Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis |
| Q38853708 | Resuming anticoagulant therapy after intracerebral bleeding |
| Q55354315 | Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis. |
| Q47891553 | Resumption of Anticoagulation After Intracranial Hemorrhage |
| Q49970899 | Reversal agents for non-vitamin K antagonist oral anticoagulants |
| Q64983401 | Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage. |
| Q36302446 | Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage |
| Q30400249 | Reversing the anticoagulation effects of dabigatran |
| Q35877931 | Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation |
| Q38937992 | Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis |
| Q39852573 | Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage. |
| Q99616760 | Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage |
| Q55446813 | Serum Magnesium Levels and Outcomes in Patients With Acute Spontaneous Intracerebral Hemorrhage. |
| Q37640888 | Spontaneous Intracerebral Hemorrhage: Management |
| Q57312974 | Stroke |
| Q52652655 | Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA-AF registry program |
| Q89599684 | Surgery for spontaneous intracerebral hemorrhage |
| Q64111058 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q38688877 | The future of atrial fibrillation management: integrated care and stratified therapy |
| Q60920824 | The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review |
| Q38636940 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. |
| Q38764867 | Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke |
| Q48282136 | Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage |
| Q40475411 | Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage. |
| Q36838308 | Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study |
| Q30240179 | What to do after the bleed: resuming anticoagulation after major bleeding. |
| Q90397785 | When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics |
| Q89276018 | [Critical care management of intracerebral hemorrhage] |
| Q87711385 | [Intensive care studies from 2015/2016] |
| Q85461139 | [Intensive care therapy of space-occupying large hemispheric infarction. Summary of the NCS/DGNI guidelines] |
| Q90251846 | [Stroke and intracerebral hemorrhage under anticoagulation or platelet inhibition-when should treatment be restarted and how?] |
| Q86939566 | [Traumatic brain injury in anticoagulated patients : Hemostatic therapy for the treatment of intracranial hemorrhage] |
Search more.